NEW YORK (GenomeWeb) – Reversing its 3 percent loss in December, the GenomeWeb Index surged nearly 9 percent in January to open 2018.

The Index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which gained nearly 6 percent, 7 percent, and 7 percent, respectively. Stock performances in the January GenomeWeb Index were largely positive as 19 of the 26 stocks saw gains and only 7 saw losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.